Related Experiment Videos
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials
Cancer Treatment and Research
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Ewing's sarcoma of the pelvis: changes over 25 years in treatment and results.
European journal of cancer (Oxford, England : 1990)·1998
Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6.
Medical and pediatric oncology·1997
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026